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The roots of Plumbago zeylanica (Plumbaginaceae) and Uvaria chamae (Annonaceae) have been used 
in folklore medicine in the management of sickle-cell disease (SCD) in South-West Nigeria. Using both 
crude methanol extract and its aqueous fraction, in vitro antisickling activities of these plant parts were 
evaluated using p-hydroxybenzoic acid and normal saline as positive and negative controls, 
respectively. Phytochemical screening of the investigated plant specimens revealed the presence of 
flavonoids, saponnins, alkaloids, tannins, cardiac glycosides free and combined anthraquinones. 
Extracts/fractions of P. zeylanica had a significantly higher (p < 0.05) antisickling activity at the tested 
concentrations of 10.0, 1.0 and 0.1 mg/ml. Therefore, the use of these plants by the traditional medical 
practitioners in the treatment of SCD in Ogun State, Nigeria is justified. The implication of these results 
is in defining the role of each plant specimen in traditional recipes for SCD management and drug 
development is presented. 
 





Sickle cell anemia is a genetic blood disorder arising from 
a point mutation in the -globin gene that leads to the 
replacement of glutamic acid residue by valine at the 
sixth position of the -chain of haemoglobin. At low 
oxygen tension, the mutant haemoglobin, sickle 
haemoglobin, polymerises inside the red blood cell into a 
gel or further into fibres leading to a drastic increase in 
the red cell deformability. As a result, micro-vascular 
occlusion arises which may lead to serious, sometimes 
fatal crises (Mehanna, 2001). 
Various approaches have been adapted in an effort to 
find agents that inhibit the polymerization of haemoglobin 
and hence prevent or reduce the occurrence of crises in 
sickle cell disease (SCD) (Iyamu et al., 2002; Akojie and 
Fung, 1992). In this regard, oxygen, carbon monoxide 
and sodium nitrite were used to reduce the amount of 
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reported that these approaches did not give the much 
needed beneficial effects. In the recent years, bone 
marrow transplantation has been found to be an efficient 
way of treating SCD. However, the cost implications, 
availability of necessary expertise and the problems of 
finding suitable donors constituted a major setback to this 
approach in developing countries (Mpiana et al., 2007). 
Currently, in clinical practice, clotrimazole, hydroxyurea 
and erythropoietin are used in SCD management, but the 
side effects of these drugs limit their clinical use (Rifai et 
al, 1995; Mehanna, 2001; Eliot et al., 2006). 
On the understanding that herbal remedies and medi-
cinal plants products from indigenous flora have long 
been used in folk medicine in the management of SCD, it 
appears that proper and in-depth scientific investigation 
on such medicinal plants could be of tremendous help in 
developing efficacious and safer drugs for SCD 
treatment. The use of phytomaterials such as Piper 
guinensis, Pterocarpa osun, Eugenia caryophylla and 
Sorghum bicolor extracts for the treatment of SCD has 





Pterocarpus santolinoides and Aloe vera were reported to 
increase the gelling time of sickle cell blood and inhibit 
sickling in vitro (Ugbor, 2006). Sofowora and Isaac- 
Sodeye (1971) reported the reversal of sickling by root 
extracts of Fagara zanthoxylloides. Terminalia catappa 
could be effective antisickling agents that inhibit 
osmotically induced haemolysis of human erythrocytes 
(Mgbemene and Ohiri, 1999). 
Research on phytomedicine for the treatment of SCD 
has led to the development of Niprisan (a herbal based 
drug) which has been patented by the National Institute 
for Pharmaceutical Research and Development (NIPRD), 
Abuja, Nigeria and produced to meet increasing global 
demand by sufferers of SCD. This development indicates 
that more of such herbal based drugs could be 
consequent upon scientific investigations on plants that 
are used in folklore medicine. Current report indicates 
that roots of Uvaria chamae (Annonaceae) and 
Plumbago zeylanica (Plumbaginaceae) are part of the 
constituents that are used in making traditional recipe for 
the management of sickle cell anemia (Egunyomi et al., 
2009). U. chamae, commonly known as finger root or 
bush banana is a climbing large shrub or small tree 
native to tropical West and Central Africa. The common 
name refers to the fruit growing in its small bunches; the 
fruit is edible and widely eaten. U. chamae is a medicinal 
plant used throughout its range to treat fevers and has 
antibiotic properties (Iwu, 1993; Bongers et al., 2005). P. 
zeylanica (commonly called Leadwort) is native to West 
Africa where its folklore medicinal uses include the 
treatment of arthritis, rheumatism, haemorrhoids, leprosy, 
stomach troubles, cutaneous and subcutaneous parasitic 
infection to mention a few (Burkill, 1985). 
In the parlance of herbal therapy, Gillete et al. (2004) 
opined that all components of a therapeutic mixture of 
plants are necessary. However, the need for the role 
definition of each component of such traditional recipe 
could not be overemphasized on the roadmap of up-
grading such traditional recipe. In this regard, the present 
work focused on phytochemical screening and evaluation 
of antisickling activities of Plumbago zeylanica and 
Uvaria chamae. This is with a view of gaining insight on 
the possible role that these plants might be playing in the 
recipe for SCD management which contains them. 
 
 
MATERIALS AND METHODS 
 
Plant collection and preparation 
 
Different plant parts such as leaves, stems, roots and fruits of P. 
zeylanica and U. chamae were collected from Iperu Remo, Ogun 
State, Nigeria. They were identified by plant taxonomist at the 
Forestry Research Institute of Nigeria, (FRIN), Ibadan, Nigeria. The 
voucher specimen numbers given were 107863 for P. zeylanica 
and 106767 for U. chamae respectively. All plant parts were 
collected for identification purpose, only the roots were used for the 
study. The dried roots were powdered using mortar and pestle. The 
Powdered samples were stored in airtight containers and properly 
labeled for further work. 






Powdered samples of each of the plant materials were used to test 
for alkaloids, saponins, tannins, combined and free anthraquinones 






Each of the dried powdered material (500 g) was extracted with 2 L 
of methanol by cold extraction for 7 days in large amber bottles with 
intermittent shaking. At the end of seven days, the crude methanol 
extract was filtered and the filtrate was concentrated using rotary 
evaporator. In another setup, dried powdered materials were 
soaked in distilled water for 3 days using the same proportion used 
for methanol extraction. The filtrates obtained thereafter were 
evaporated to dryness to obtain aqueous extract. Thereafter, both 
crude methanol extract and aqueous extract were serially diluted 
with normal saline (0.9% NaCl) to give 10, 1.0 and 0.1 mg/ml 
solutions which were used for subsequent antisickling assay. 
 
 
Blood collection and preparation 
 
Blood (0.5 ml) was obtained by venipuncture from a sickle cell 
disease patient (HbSS) volunteer in accordance with Institutional 
protocols. The volunteer who gave informed consent was in steady 
state from Haematology Day Care Unit of the Olabisi Onabanjo 
University Teaching Hospital, Sagamu, Nigeria. Blood was collected 
in sodium EDTA bottles and the content was thoroughly mixed by 
gently rolling the bottle. The blood sample was centrifuged to 
remove serum and the packed erythrocytes were obtained and 
washed with normal saline as described by Egunyomi et al. (2009). 
 
 
Bioassay of plant extracts for antisickling activity 
 
Bioassay of crude methanol extract and aqueous extract of the two 
plant materials for antisickling activity was carried out within two 
approaches, namely: inhibition of sickling (antisickling) and reversal 
of sickled erythrocytes. 
 Evaluation of antisickling activities of the extracts/fractions was 
carried out using a modified method of Sofowora et al. (1979). The 
washed erythrocytes (0.5 ml) were mixed with 0.5 ml of the 
concentration of the test extracts/fractions in uncovered test tubes 
and mixed together. Samples were taken from the different mixtures 
and the remaining was incubated at 37°C for 3 h, while shaking 
occasionally. Five drops of sodium metabisulphite (2%) were added 
to the mixture, mixed thoroughly and sealed with liquid paraffin. 
Samples were then taken in duplicates from the different mixtures 
at 0 min after which the systems were incubated at 37°C. The 
samples were taken again at 30 min intervals until four more 
readings were taken. The procedure for smear preparation and 
counting of sickled and unsickled cells was as described by 
Egunyomi et al. (2009). Two types of controls were employed in this 
bioassay. A positive control using p-hydroxybenzoic acid at 5 mg/ml 
and normal saline as negative control. The percentage inhibition of 
sickling was calculated using the formula of Moody et al. (2003).  
Evaluation of different plant extracts/fractions for sickling reversal 
activity was carried out according to the procedure of Oduola et al. 
(2006). The washed erythrocytes (0.5 ml) was mixed with 0.5 ml of 
freshly prepared sodium metabisulphite (2%) in a clean test tube 
and incubated at 37°C for 30 min. A drop of the mixture was viewed 
under the microscope. Equal volume of normal saline/extract/ 
fraction was added to the blood-metabisulphite mixture in a different 
test tube and incubated at 37°C for another 30 min. Samples were 
taken at 0 min and at 30 min interval for up  to  2 h.  The  procedure 













Flavonoids Alkaloids Saponins Tannins 
P. zeylanica + + - + - + + 




described by Egunyomi et al (2009) was used for smear 





Data obtained were expressed as means. The statistical signifi-
cance of differences was assessed using analysis of variance 
(ANOVA). A two-tailed p value of less than 0.05 was considered to 





Table 1 shows the results for screened phytochemicals of 
the investigated plant materials. The two specimens 
contained flavonoids, free and combined anthraquinones, 
while P. zeylanica contained saponins and tannins in 
addition and U. chamae contained cardiac glycosides 
and alkaloids. In Tables 2 and 3, the antisickling activities 
of both methanol and aqueous extracts of P. zeylanica 
and U. chamae are presented. At the tested concen-
trations of 10 and 1 mg/ml, both the methanol and 
aqueous extracts of P. zeylanica exhibited antisickling 
activity that compared favourably with that exhibited by p-
hydroxy benzoic acid (PHBA) (positive control). This 
exhibited antisickling activity was concentration depen-
dent. Also, the antisickling activity exhibited by the 
aqueous extract of P. zeylanica was significantly higher 
(p < 0.05) at the three tested concentrations of 10, 1 and 
0.1 mg/ml when compared to its methanol extract. In a 
trend that contrasts the antisickling activity of P. 
zeylanica, U. chamae had a very weak antisickling 
activity. Even at the tested highest concentration of 10 
mg/ml, both the methanol and aqueous extracts of the 
root of this plant exhibited antisickling activity that was 
significantly lower (p < 0.05) than that exhibited by the 
positive control whose concentration was 5 mg/ml. 
The result of sickling reversal bioassay shown in 
Tables 2 and 3 revealed a trend which was similar to that 
of the presently reported antisickling activities of both P. 
zeylanica and U. chamae. The sickling reversal activities 
of the investigated plant parts were concentration-
dependent and plant specimen-dependent. For the P 
zeylanica, the solvent used in extraction had no significant 





The results of screened phytochemicals  for  roots  of  the  
two plants investigated revealed the presence of free and 
combined anthraquinones, saponins, alkaloids, tannins, 
flavonoids and cardiac glycosides. This result is in agree-
ment with the report of Egunyomi et al. (2009), with an 
exception of tannins and flavonoids which were not 
reported to be present in a traditional recipe which had P. 
zeylanica and U. chamae as its constituents. However, 
this present report further indicates the specific phyto-
chemicals that are being contributed by each of the P. 
zeylanica and U. chamae. Anthraquinones act on the 
gastro-intestinal tract to increase the peristalsic action 
(Evans, 1989). In cases where sickle cell patients com-
plain of constipation, the anthraquinones present in the 
investigated plant may be useful as a mild laxative. 
Kenner and Yves (1996) stated that cardiac glycosides 
have antispasmodic properties and act as good seda-
tives. The contribution of U. chamae in respect of cardiac 
glycosides is an indication that a recipe that contain U. 
chamae root may be potent to relieve symptoms of 
cardiac insufficiency, coughs and circulatory problems. 
Result of the antisickling assay of root of P. zeylanica 
and U. chamae establish their abilities to inhibit sickling 
under hypoxic condition, thus justifying their use in 
folklore medicine for SCD management. However, the 
present study indicates further that the antisickling 
potential of the extracts of the investigated plant decr-
eased after 1 h when compared to that of the positive 
control whose antisickling potential was maintained 
throughout the 2 h incubation. Consequently, results from 
this study suggest that the antisickling activity of U. 
chamae was lower than that of P. zeylanica. However, 
the weakness of the former in terms of lower antisickling 
activity was compensated for in terms of presence of 
phytochemicals such as cardiac glycosides and alkaloids 
which were absent in the latter. Alkaloids are nerve 
stimulants, convulsants and muscle relaxant, while car-
diac glycosides act as good sedatives and have anti-
spasmodic properties (Kenner and Yves, 1996). It then 
becomes evidently clear that each constituent of the 
traditional recipe used in SCD management have a 
peculiar role that it is performing. This corroborates the 
opinion of Gillete et al. (2004) that all components of a 
therapeutic mixture of plants are necessary. 
Niprisan (a herbal based drug for SCD management) 
was developed from four plants: P. guinensis, P. osun, E 
caryophylla and S. bicolor. Results from the present 
study are possibly suggesting the roles played by P. 
zeylanica and U. chamae are playing in the traditional 
recipe of which they are constituents. More of  such study  


















10.0 1.0 0.1 10.0 1.0 0.1 
0 - (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
30 - (2) 48 (55) 64 (48) 56 (40) 16 (33) 68 (50) 60 (40) 20 (32) 
60 - (4) 50 (59) 73 (51) 66 (41) 35 (34) 77 (52) 69 (44) 39 (40) 
90 - (5) 53 (62) 64 (54) 58 (44) 17 (38) 69 (55) 61 (51) 23 (46) 
120 - (8) 55 (63) 45 (60) 39 (57) 9 (51) 51 (58) 45 (55) 18 (51) 
 



















10.0 1.0 0.1 10.0 1.0 0.1 
0 - (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
30 - (2) 48 (55) 36 (26) 20 (12) 10 (5) 20 (18) 16 (6) 6 (0) 
60 - (4) 50 (59) 52 (28) 39 (18) 15 (5) 39 (21) 20 (6) 7 (1) 
90 - (5) 53 (62) 35 (28) 23 (20) 10 (8) 23 (23) 15 (8) 5 (2) 
120 - (8) 55 (63) 18 (30) 18 (22) 9 (9) 18 (26) 9 (9) 3 (3) 
 





should be undertaken on other constituents of traditional 
recipes on a road map of development of other phyto-
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